SCHEMBL8372113

SCHEMBL8372113

CO[C@H]1O[C@H](COCc2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H]1OC(=O)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.56
PTPN1 P18031 12/20 0.55
PTPN2 P17706 3/20 0.51
PTPN6 P29350 2/20 0.51
PTPN11 Q06124 2/20 0.51
SSTR1 P30872 1/20 0.47
SSTR2 P30874 1/20 0.47
SSTR4 P31391 1/20 0.47
SSTR3 P32745 1/20 0.47
SSTR5 P35346 1/20 0.47
LGALS8 O00214 1/20 0.44
LGALS3 P17931 1/20 0.43
LGALS4 P56470 1/20 0.43
TACR2 P21452 1/20 0.42
GJB2 P29033 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8372110 1.00 NT5E (0.56) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL8468516 0.96 NT5E (0.55) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL8331303 0.96 NT5E (0.55) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL14428921 0.93 NT5E (0.63) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL7641984 0.92 NT5E (0.51) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL8328522 0.91 NT5E (0.50) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL8329966 0.91 NT5E (0.50) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL3319899 0.90 NT5E (0.51) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL3319903 0.90 NT5E (0.51) NT5EPTPN1PTPN2PTPN6PTPN11
SCHEMBL3319905 0.90 NT5E (0.51) NT5EPTPN1PTPN2PTPN6PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0565590-B1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) ANTEX BIOLOG INC (US) 1999-03-03 EP disclosed
US-5843463-A Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae ANTEXBIOLOGICS, INC. (US) 1998-12-01 US disclosed
US-5721115-A GENETIC ENGINEERING ANTEX BIOLOGICS, INC. (US) 1998-02-24 US disclosed
US-5679547-A COMPLEXING ANTEX BIOLOGICS FORMERLLY MICROCARB INC. (US) 1997-10-21 US disclosed
EP-0647139-A4 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR -i(HAEMOPHILUS INFLUENZAE). MICROCARB INC (US) 1997-09-03 EP disclosed
EP-0565590-A4 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR -i(HAEMOPHILUS INFLUENZAE). MICROCARB INC (US) 1995-07-05 EP disclosed
EP-0647139-A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) MICROCARB, INC. (US) 1995-04-12 EP disclosed
WO-1994000149-A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) MICROCARB INC. (US) 1994-01-06 WO disclosed
EP-0565590-A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) MicroCarb Inc. (US) 1993-10-20 EP disclosed
WO-1992010936-A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) MICROCARB, INC. (US) 1992-07-09 WO disclosed